Literature DB >> 21514832

Synthesis of optically active dodecaborate-containing L-amino acids for BNCT.

Shintaro Kusaka1, Yoshihide Hattori, Kouki Uehara, Tomoyuki Asano, Shinji Tanimori, Mitsunori Kirihata.   

Abstract

A convenient and simple synthetic method of dodecaboratethio-L-amino acid, a new class of tumor-seeking boron carrier for BNCT, was accomplished from S-cyanoethylthioundecahydro-closo-dodecaborate (S-cyanoethyl-(10)BSH, [(10)B(12)H(11)](2-)SCH(2)CH(2)CN) and bromo-L-α-amino acids by nearly one step S-alkylation. An improved synthesis of S-cyanoethyl-(10)BSH, a key starting compound for S-alkylation, was also performed by Michael addition of (10)BSH with acryronitrile in high yield. Four kinds of new dodecaboratethio-L-amino acids were obtained in optically pure form without the need for any optical resolution. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514832     DOI: 10.1016/j.apradiso.2011.03.042

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

1.  Dodecaborate Conjugates Targeting Tumor Cell Overexpressing Translocator Protein for Boron Neutron Capture Therapy.

Authors:  Yoshihide Hattori; Miki Ishimura; Youichirou Ohta; Hiroshi Takenaka; Shinji Kawabata; Mitsunori Kirihata
Journal:  ACS Med Chem Lett       Date:  2021-12-01       Impact factor: 4.345

2.  "Carboranyl-cysteine"-Synthesis, Structure and Self-Assembly Behavior of a Novel α-Amino Acid.

Authors:  Tianyu He; Jennifer C Misuraca; Rabi A Musah
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

3.  Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy.

Authors:  Koji Takeuchi; Yoshihide Hattori; Shinji Kawabata; Gen Futamura; Ryo Hiramatsu; Masahiko Wanibuchi; Hiroki Tanaka; Shin-Ichiro Masunaga; Koji Ono; Shin-Ichi Miyatake; Mitsunori Kirihata
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.